Kyocera Co. (OTCMKTS:KYOCY) Sees Large Growth in Short Interest

Kyocera Co. (OTCMKTS:KYOCY) was the target of a large growth in short interest in March. As of March 15th, there was short interest totalling 30,200 shares, a growth of 179.6% from the February 28th total of 10,800 shares. Based on an average daily volume of 81,700 shares, the short-interest ratio is currently 0.4 days. Currently, 0.0% of the company’s stock are sold short.

Kyocera Price Performance

Shares of KYOCY opened at $11.46 on Friday. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.97 and a current ratio of 3.20. The firm has a market capitalization of $16.14 billion, a PE ratio of 81.86, a P/E/G ratio of 3.05 and a beta of 0.25. The stock has a 50 day simple moving average of $11.26 and a 200 day simple moving average of $10.81. Kyocera has a 52-week low of $9.21 and a 52-week high of $13.38.

Kyocera (OTCMKTS:KYOCY) last issued its quarterly earnings data on Monday, February 3rd. The company reported ($0.08) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.16 by ($0.24). Kyocera had a return on equity of 0.82% and a net margin of 1.34%. Sell-side analysts predict that Kyocera will post 0.32 EPS for the current fiscal year.

About Kyocera

Kyocera Corporation develops, produces, and distributes products based on fine ceramic technologies in Japan, rest of Asia, Europe, the United States, and internationally. It operates through Core Components Business, Electronic Components Business, and Solutions Business segments. The Core Components Business segment offers components, such as fine ceramic components for semiconductor processing equipment, automotive camera modules, and ceramic packages, as well as organic packages and boards to protect electronic components and ICs to industrial machinery, automotive-related, and the information and communication-related markets; optical components, and jewelry and applied ceramic related products; and medical devices comprising prosthetic joints and dental implants.